The Drug and Carcinogen-DNA Interactions training program provides a unique opportunity for interdisciplinary training in cancer across the boundary between chemistry and biology. Since its initiation in 1990 the training grant has provided a mechanism to provide biology students with a solid foundation in the molecular basis for cancer, and provided chemistry and medicinal chemistry students with a comprehensive understanding of the biological consequences of events at the molecular level leading to cancer. Training within the traditional disciplines of chemistry and biology is generally highly focused. A chemist may specialize in the synthesis of antitumor compounds, but is unlikely to complement that skill with a corresponding knowledge of the biological consequences of the action of these molecules on cells. Correspondingly a biology student studying the molecular biology of oncogenes, is unlikely to acquire knowledge about the molecular details of the interactions of transcription factors and small molecules with DNA. The training grant, through its monthly meetings, courses, seminar program, and collaborations between preceptor laboratories provides the framework to accomplish the cross-training of both groups of scientists. The training program provides training in three principal areas, structural biology of DNA, DNA-directed drug design, and biochemistry and molecular biology of DNA. In addition, translational and clinical aspects of cancer are to be incorporated into the program through a cooperative training effort with the Indiana University Cancer Center. Fourteen of the preceptors are active researchers in the areas described above, and are experienced mentors of graduate students. The active support of these investigators is over $4,382,333 (direct cost per year, see Table 4, Active Research Support). The proposed continuation of the training program will allow us to recruit outstanding students, including minority students, who are interested in molecular biology, chemistry of DNA, and drug design. The training grant is used to attract new students with these interests to Purdue University, and encourage well-qualified present students to consider a career in cancer research. The trainees receive formal training through course work on specific areas of cancer research as well as specialized training through specific research projects. Overall the program provides students with unique training in interdisciplinary cancer research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009634-14
Application #
6948848
Study Section
Subcommittee G - Education (NCI)
Program Officer
Eckstein, David J
Project Start
1990-09-30
Project End
2007-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
14
Fiscal Year
2005
Total Cost
$256,892
Indirect Cost
Name
Purdue University
Department
Type
Organized Research Units
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Woods, James R; Mo, Huaping; Bieberich, Andrew A et al. (2011) Fluorinated amino-derivatives of the sesquiterpene lactone, parthenolide, as (19)f NMR probes in deuterium-free environments. J Med Chem 54:7934-41
Nyland, Rodney L; Luo, Meihua; Kelley, Mark R et al. (2010) Design and synthesis of novel quinone inhibitors targeted to the redox function of apurinic/apyrimidinic endonuclease 1/redox enhancing factor-1 (Ape1/ref-1). J Med Chem 53:1200-10
Cinelli, Maris A; Morrell, Andrew E; Dexheimer, Thomas S et al. (2010) The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode. Bioorg Med Chem 18:5535-52
Cinelli, Maris A; Morrell, Andrew; Dexheimer, Thomas S et al. (2008) Design, synthesis, and biological evaluation of 14-substituted aromathecins as topoisomerase I inhibitors. J Med Chem 51:4609-19
Luo, Meihua; Delaplane, Sarah; Jiang, Aihua et al. (2008) Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 10:1853-67
Morrell, Andrew; Placzek, Michael; Parmley, Seth et al. (2007) Optimization of the indenone ring of indenoisoquinoline topoisomerase I inhibitors. J Med Chem 50:4388-404
Antony, Smitha; Agama, Keli K; Miao, Ze-Hong et al. (2007) Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance. Cancer Res 67:10397-405
Morrell, Andrew; Placzek, Michael; Parmley, Seth et al. (2007) Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization. J Med Chem 50:4419-30
Fingerman, Ian M; Li, Hui-Chun; Briggs, Scott D (2007) A charge-based interaction between histone H4 and Dot1 is required for H3K79 methylation and telomere silencing: identification of a new trans-histone pathway. Genes Dev 21:2018-29
Morrell, Andrew; Jayaraman, Muthusamy; Nagarajan, Muthukaman et al. (2006) Evaluation of indenoisoquinoline topoisomerase I inhibitors using a hollow fiber assay. Bioorg Med Chem Lett 16:4395-9

Showing the most recent 10 out of 60 publications